Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7884 |
Intermediate Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD2680 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2681 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3511 |
Discontinued |
0.7581 |
Intermediate Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD3964 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2246 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2248 |
Approved |
0.7429 |
Intermediate Similarity |
NPD2366 |
Approved |
0.741 |
Intermediate Similarity |
NPD2670 |
Approved |
0.7345 |
Intermediate Similarity |
NPD2842 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD3965 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD3251 |
Approved |
0.7263 |
Intermediate Similarity |
NPD1276 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD3170 |
Approved |
0.7225 |
Intermediate Similarity |
NPD1802 |
Approved |
0.7225 |
Intermediate Similarity |
NPD1801 |
Approved |
0.7222 |
Intermediate Similarity |
NPD955 |
Approved |
0.7214 |
Intermediate Similarity |
NPD3874 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD5871 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD7528 |
Approved |
0.7182 |
Intermediate Similarity |
NPD3252 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD6654 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD5186 |
Approved |
0.7158 |
Intermediate Similarity |
NPD5183 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5928 |
Phase 1 |
0.7127 |
Intermediate Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6021 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD2249 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6457 |
Approved |
0.7104 |
Intermediate Similarity |
NPD2247 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7238 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD7256 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1109 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1110 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7476 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD6645 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD3290 |
Approved |
0.6985 |
Remote Similarity |
NPD3289 |
Phase 3 |
0.697 |
Remote Similarity |
NPD1198 |
Approved |
0.6954 |
Remote Similarity |
NPD7880 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD6296 |
Discontinued |
0.694 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD6874 |
Approved |
0.6927 |
Remote Similarity |
NPD1166 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.69 |
Remote Similarity |
NPD1199 |
Approved |
0.69 |
Remote Similarity |
NPD1200 |
Approved |
0.6895 |
Remote Similarity |
NPD6211 |
Clinical (unspecified phase) |
0.6895 |
Remote Similarity |
NPD5445 |
Approved |
0.6869 |
Remote Similarity |
NPD7186 |
Phase 3 |
0.6866 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6862 |
Remote Similarity |
NPD2359 |
Approved |
0.6862 |
Remote Similarity |
NPD5919 |
Clinical (unspecified phase) |
0.6856 |
Remote Similarity |
NPD6793 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.685 |
Remote Similarity |
NPD1880 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD5860 |
Discontinued |
0.6842 |
Remote Similarity |
NPD5900 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6357 |
Discontinued |
0.6832 |
Remote Similarity |
NPD7626 |
Approved |
0.6832 |
Remote Similarity |
NPD7627 |
Approved |
0.6831 |
Remote Similarity |
NPD1012 |
Discontinued |
0.6827 |
Remote Similarity |
NPD4356 |
Discontinued |
0.6825 |
Remote Similarity |
NPD2361 |
Approved |
0.6816 |
Remote Similarity |
NPD3627 |
Approved |
0.6806 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD7064 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD3783 |
Clinical (unspecified phase) |
0.6789 |
Remote Similarity |
NPD5521 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD2434 |
Approved |
0.6774 |
Remote Similarity |
NPD710 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD2341 |
Discontinued |
0.6766 |
Remote Similarity |
NPD3297 |
Approved |
0.6765 |
Remote Similarity |
NPD7891 |
Discontinued |
0.675 |
Remote Similarity |
NPD5515 |
Phase 2 |
0.6749 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD4597 |
Approved |
0.6743 |
Remote Similarity |
NPD4598 |
Approved |
0.6722 |
Remote Similarity |
NPD8330 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD5071 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD553 |
Approved |
0.6707 |
Remote Similarity |
NPD9567 |
Approved |
0.6707 |
Remote Similarity |
NPD552 |
Approved |
0.6706 |
Remote Similarity |
NPD9471 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD3684 |
Discontinued |
0.6701 |
Remote Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.6699 |
Remote Similarity |
NPD5866 |
Approved |
0.6686 |
Remote Similarity |
NPD7752 |
Approved |
0.6686 |
Remote Similarity |
NPD9694 |
Discovery |
0.6686 |
Remote Similarity |
NPD7753 |
Approved |
0.6686 |
Remote Similarity |
NPD7083 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD160 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD1559 |
Discontinued |
0.6684 |
Remote Similarity |
NPD5637 |
Discontinued |
0.6683 |
Remote Similarity |
NPD4467 |
Phase 2 |
0.6683 |
Remote Similarity |
NPD4465 |
Phase 2 |
0.6683 |
Remote Similarity |
NPD3298 |
Approved |
0.6667 |
Remote Similarity |
NPD2514 |
Approved |
0.6667 |
Remote Similarity |
NPD1913 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD6045 |
Phase 3 |
0.665 |
Remote Similarity |
NPD4496 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD1543 |
Discontinued |
0.6648 |
Remote Similarity |
NPD2114 |
Discontinued |
0.6648 |
Remote Similarity |
NPD3229 |
Phase 2 |
0.6635 |
Remote Similarity |
NPD7538 |
Clinical (unspecified phase) |
0.6633 |
Remote Similarity |
NPD3154 |
Approved |
0.6633 |
Remote Similarity |
NPD3153 |
Approved |
0.6633 |
Remote Similarity |
NPD4302 |
Clinical (unspecified phase) |
0.663 |
Remote Similarity |
NPD3812 |
Clinical (unspecified phase) |
0.663 |
Remote Similarity |
NPD1670 |
Discontinued |
0.6628 |
Remote Similarity |
NPD756 |
Suspended |
0.6618 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6616 |
Remote Similarity |
NPD4258 |
Approved |
0.6616 |
Remote Similarity |
NPD4259 |
Approved |
0.6615 |
Remote Similarity |
NPD3793 |
Phase 3 |
0.6614 |
Remote Similarity |
NPD1839 |
Phase 1 |
0.6611 |
Remote Similarity |
NPD4161 |
Discontinued |
0.661 |
Remote Similarity |
NPD1195 |
Approved |
0.6602 |
Remote Similarity |
NPD6250 |
Discontinued |
0.6602 |
Remote Similarity |
NPD5102 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD4515 |
Suspended |
0.6597 |
Remote Similarity |
NPD7449 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD5466 |
Approved |
0.6587 |
Remote Similarity |
NPD8027 |
Approved |
0.6587 |
Remote Similarity |
NPD4082 |
Approved |
0.6587 |
Remote Similarity |
NPD2906 |
Approved |
0.6587 |
Remote Similarity |
NPD2907 |
Approved |
0.6585 |
Remote Similarity |
NPD5848 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD956 |
Clinical (unspecified phase) |
0.6575 |
Remote Similarity |
NPD2737 |
Clinical (unspecified phase) |
0.6573 |
Remote Similarity |
NPD1196 |
Approved |
0.6571 |
Remote Similarity |
NPD7272 |
Discontinued |
0.6567 |
Remote Similarity |
NPD4418 |
Discontinued |
0.6566 |
Remote Similarity |
NPD3398 |
Discontinued |
0.6561 |
Remote Similarity |
NPD2821 |
Approved |
0.6553 |
Remote Similarity |
NPD6478 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD4668 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD5227 |
Clinical (unspecified phase) |
0.655 |
Remote Similarity |
NPD4740 |
Approved |
0.6545 |
Remote Similarity |
NPD5997 |
Discontinued |
0.6545 |
Remote Similarity |
NPD6199 |
Discontinued |
0.6544 |
Remote Similarity |
NPD3912 |
Discontinued |
0.6538 |
Remote Similarity |
NPD5586 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD5548 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD7560 |
Approved |
0.6533 |
Remote Similarity |
NPD5114 |
Approved |
0.6533 |
Remote Similarity |
NPD5112 |
Approved |
0.6533 |
Remote Similarity |
NPD5113 |
Approved |
0.6532 |
Remote Similarity |
NPD3140 |
Approved |
0.6532 |
Remote Similarity |
NPD3142 |
Approved |
0.6532 |
Remote Similarity |
NPD1393 |
Approved |
0.6528 |
Remote Similarity |
NPD5600 |
Discontinued |
0.6528 |
Remote Similarity |
NPD1212 |
Approved |
0.6528 |
Remote Similarity |
NPD5334 |
Clinical (unspecified phase) |
0.6526 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.6522 |
Remote Similarity |
NPD1557 |
Discontinued |
0.6522 |
Remote Similarity |
NPD1092 |
Approved |
0.6522 |
Remote Similarity |
NPD1093 |
Approved |
0.6512 |
Remote Similarity |
NPD5496 |
Approved |
0.6512 |
Remote Similarity |
NPD5519 |
Discontinued |
0.6507 |
Remote Similarity |
NPD4642 |
Clinical (unspecified phase) |
0.6505 |
Remote Similarity |
NPD5294 |
Clinical (unspecified phase) |
0.6505 |
Remote Similarity |
NPD7316 |
Discontinued |
0.65 |
Remote Similarity |
NPD5994 |
Discontinued |
0.6497 |
Remote Similarity |
NPD927 |
Approved |
0.6493 |
Remote Similarity |
NPD4493 |
Discontinued |
0.6486 |
Remote Similarity |
NPD6570 |
Approved |
0.6486 |
Remote Similarity |
NPD6386 |
Approved |
0.6486 |
Remote Similarity |
NPD6571 |
Approved |
0.6486 |
Remote Similarity |
NPD6385 |
Approved |
0.6482 |
Remote Similarity |
NPD5620 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD8281 |
Discontinued |
0.6479 |
Remote Similarity |
NPD4679 |
Discontinued |
0.6477 |
Remote Similarity |
NPD7142 |
Discontinued |
0.6474 |
Remote Similarity |
NPD3983 |
Phase 3 |
0.6474 |
Remote Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.6473 |
Remote Similarity |
NPD7597 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD850 |
Approved |
0.6471 |
Remote Similarity |
NPD849 |
Approved |
0.6471 |
Remote Similarity |
NPD848 |
Approved |
0.6465 |
Remote Similarity |
NPD5632 |
Approved |
0.6458 |
Remote Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD7035 |
Approved |
0.6455 |
Remote Similarity |
NPD7036 |
Phase 3 |
0.6452 |
Remote Similarity |
NPD7317 |
Phase 3 |
0.6447 |
Remote Similarity |
NPD7546 |
Discontinued |
0.6443 |
Remote Similarity |
NPD3050 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD4456 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD5192 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD6593 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD2820 |
Phase 3 |
0.6422 |
Remote Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.6421 |
Remote Similarity |
NPD2162 |
Clinical (unspecified phase) |
0.6415 |
Remote Similarity |
NPD5416 |
Discontinued |
0.6409 |
Remote Similarity |
NPD4041 |
Approved |
0.6408 |
Remote Similarity |
NPD2339 |
Phase 3 |
0.6406 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6402
|
Remote Similarity |
NPD3257 |
Approved |